Immediate Impact
12 standout
Citing Papers
Management of Impulse Control and Related Disorders in Parkinson's Disease: An Expert Consensus
2024 Standout
Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?
2024 Standout
Works of Solène Ansquer being referenced
Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Solène Ansquer | 62 | 1 | 20 | 26 | 6 | 87 | |
| Juha O. Rinne | 50 | 16 | 56 | 7 | 156 | ||
| Sophie K. Elvig | 63 | 15 | 15 | 18 | 5 | 198 | |
| Alexandra Hopkins | 38 | 17 | 89 | 5 | 152 | ||
| Monia Lobina | 65 | 4 | 8 | 49 | 5 | 192 | |
| Michael A. Kelberman | 39 | 2 | 22 | 43 | 11 | 122 | |
| Paola Piccardi | 44 | 9 | 40 | 5 | 142 | ||
| M.H. Azevedo | 43 | 12 | 11 | 7 | 136 | ||
| Scott J. Thompson | 69 | 7 | 16 | 50 | 5 | 202 | |
| Anais Rodriguez-Thompson | 22 | 1 | 5 | 60 | 7 | 126 | |
| Simon D. Fisher | 90 | 1 | 19 | 96 | 7 | 149 |
All Works
Loading papers...